Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Abiomed Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Abiomed Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016
Accounts payable
Accrued expenses
Deferred revenue
Other current liabilities
Current portion of capital lease obligation
Current liabilities
Other long-term liabilities
Contingent consideration
Deferred tax liabilities
Capital lease obligation, net of current portion
Long-term liabilities
Total liabilities
Class B Preferred Stock, $.01 par value; none issued and outstanding
Common stock, $.01 par value
Additional paid in capital
Retained earnings (accumulated deficit)
Treasury stock at cost
Accumulated other comprehensive loss
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).

Accounts Payable
Accounts payable exhibited a generally increasing trend from mid-2016 through mid-2022, rising from 8,372 thousand USD to approximately 35,070 thousand USD. There were notable fluctuations, with periodic decreases followed by rebounds, but the overall pattern indicates growth in short-term obligations to suppliers.
Accrued Expenses
Accrued expenses showed a consistent upward trajectory over the period, increasing from 26,257 thousand USD in mid-2016 to a peak above 79,000 thousand USD in late 2022. This indicates growing obligations for incurred but not yet paid expenses, with some seasonal variability visible within individual years.
Deferred Revenue
Deferred revenue steadily increased from around 8,590 thousand USD in mid-2016 to a value near 26,000 thousand USD by the end of the dataset. The increases, while somewhat irregular quarter-over-quarter, reflect growing advance payments or unearned income during the period.
Other Current Liabilities
Data for other current liabilities was sparse but appeared from early 2019 onwards, ranging between approximately 2,379 thousand USD and 5,579 thousand USD. These liabilities displayed some variability without a clear increasing or decreasing trend.
Current Portion of Capital Lease Obligation
This liability item is reported with limited data, primarily in 2016 and 2017 quarters, showing a small but steady increase within that timeframe, going from 740 thousand USD to 851 thousand USD, then ceasing to be recorded.
Current Liabilities (Total)
The aggregate current liabilities, encompassing the aforementioned components, showed a strong upward trend from 43,219 thousand USD in June 2016 to a peak over 140,000 thousand USD in late 2022. The changes reflect overall growth in short-term financial obligations.
Other Long-term Liabilities
Other long-term liabilities were initially minimal but displayed substantial increases in the focal years, particularly around 2019, reaching values up to approximately 12,227 thousand USD before gradually declining. These changes indicate shifting long-term obligations over time.
Contingent Consideration
The contingent consideration steadily increased from roughly 7,739 thousand USD in mid-2016 to a plateau around the mid-to-high 20,000 thousands by 2021. A notable drop occurred in the latter part of 2022, suggesting settlement or remeasurement of contingent liabilities.
Deferred Tax Liabilities
Deferred tax liabilities remained relatively stable but low, fluctuating slightly between approximately 689 thousand USD and 903 thousand USD, except for a temporary spike around 2020 where it exceeded 4,000 thousand USD, indicating some exceptional tax timing differences during that period.
Capital Lease Obligation, net of Current Portion
Data for this item was limited to 2016-2017, showing a gradual decline from 15,961 thousand USD to 15,110 thousand USD, indicating the amortization or repayment of these lease obligations.
Long-term Liabilities (Total)
Long-term liabilities exhibited significant volatility with a notable increase from 8,766 thousand USD in mid-2016, peaking intensely above 46,000 thousand USD by late 2020, before moderating to around 22,697 thousand USD by late 2022. This suggests periods of increased borrowing or accrual of long-term obligations followed by repayment or restructuring.
Total Liabilities
Total liabilities combined both current and long-term obligations and displayed a rising trend from approximately 51,985 thousand USD to over 167,000 thousand USD during the analyzed period. The liabilities peaked around 2022, reflecting an expansion in the company's total financial obligations.
Common Stock
Common stock par value remained relatively constant, increasing slightly from 430 thousand USD to approximately 456 thousand USD, indicating minor changes in share capital through the period.
Additional Paid-in Capital
Additional paid-in capital steadily increased from about 520,842 thousand USD in June 2016 to approximately 904,755 thousand USD by the latest period, reflecting ongoing equity financing or capitalization events.
Retained Earnings
Retained earnings saw substantial improvement, transitioning from a negative balance of -86,165 thousand USD to a positive balance exceeding 1,125,000 thousand USD. This reflects sustained profitability and earnings retention over time.
Treasury Stock at Cost
Treasury stock value grew significantly in absolute terms (negative balance deepened), from -41,691 thousand USD to nearly -444,000 thousand USD, indicating continuous repurchase or holdings of company stock during the period.
Accumulated Other Comprehensive Loss
This category displayed increasing cumulative losses over time, starting at -16,089 thousand USD and increasing to -46,645 thousand USD. The pattern suggests growing unrealized losses or other comprehensive expense components.
Stockholders’ Equity
Stockholders’ equity consistently expanded from approximately 377,327 thousand USD to over 1,539,787 thousand USD, signaling robust growth in net assets alongside increases in retained earnings and paid-in capital, despite treasury stock and comprehensive losses.
Total Liabilities and Stockholders’ Equity
The sum of liabilities and stockholders’ equity showed a strong growth trajectory from about 429,312 thousand USD to approximately 1,696,544 thousand USD. This overall increase corresponds with expansion in the company’s balance sheet size over the analyzed period.